Evaluating the cost-effectiveness of clinical and public health measures

被引:123
作者
Graham, JD
Corso, PS
Morris, JM
Segui-Gomez, M
Weinstein, MC
机构
[1] Harvard Univ, Sch Publ Hlth, Ctr Risk Anal, Boston, MA 02115 USA
[2] Ctr Dis Control & Prevent, Div Prevent Res & Anal, Prevent Effectiveness Branch, Atlanta, GA 30333 USA
关键词
cost-effectiveness; cancer; heart disease; trauma; infectious disease;
D O I
10.1146/annurev.publhealth.19.1.125
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Cost-effectiveness analysis, an analytic tool that expresses as a ratio the cost of obtaining an additional unit of health outcome, can help decision makers achieve more health protection for the same or less cost. We characterize the state of the cost-effectiveness analysis literature by reviewing how this technique is applied to various clinical and public health interventions. We describe the results of cost-effectiveness analyses for over 40 interventions to reduce cancer, heart disease, trauma, and infectious disease. The cost-effectiveness ratios for these interventions vary enormously, from interventions that save money to those that cost more than $1 million per year of life gained. The methods used to derive the cost-effectiveness ratios also vary considerably, and we summarize this variation within each health area. Greater uniformity of analytical practice will be necessary if cost-effectiveness analysis is to became a more influential tool in debates about resource allocation.
引用
收藏
页码:125 / 152
页数:28
相关论文
共 75 条
[1]   SAFETY AND COST-EFFECTIVENESS OF SOLVENT-DETERGENT-TREATED PLASMA - IN SEARCH OF A ZERO-RISK BLOOD-SUPPLY [J].
AUBUCHON, JP ;
BIRKMEYER, JD .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1994, 272 (15) :1210-1214
[2]   THE COST-EFFECTIVENESS OF PREOPERATIVE AUTOLOGOUS BLOOD DONATION FOR TOTAL HIP AND KNEE REPLACEMENT [J].
BIRKMEYER, JD ;
GOODNOUGH, LT ;
AUBUCHON, JP ;
NOORDSIJ, PG ;
LITTENBERG, B .
TRANSFUSION, 1993, 33 (07) :544-551
[3]   COST-EFFECTIVENESS OF PREOPERATIVE AUTOLOGOUS DONATION IN CORONARY-ARTERY BYPASS-GRAFTING [J].
BIRKMEYER, JD ;
AUBUCHON, JP ;
LITTENBERG, B ;
OCONNOR, GT ;
NEASE, RF ;
NUGENT, WC ;
GOODNOUGH, LT .
ANNALS OF THORACIC SURGERY, 1994, 57 (01) :161-169
[4]  
BLINCOE LJ, 1996, EC COST MOTOR VEHICL
[5]   A REAPPRAISAL OF HEPATITIS-B VIRUS VACCINATION STRATEGIES USING COST-EFFECTIVENESS ANALYSIS [J].
BLOOM, BS ;
HILLMAN, AL ;
FENDRICK, AM ;
SCHWARTZ, JS .
ANNALS OF INTERNAL MEDICINE, 1993, 118 (04) :298-306
[6]  
Brasel KJ, 1996, ARCH SURG-CHICAGO, V131, P619
[7]   Declining value of alanine aminotransferase in screening of blood donors to prevent posttransfusion hepatitis B and C virus infection [J].
Busch, MP ;
Korelitz, JJ ;
Kleinman, SH ;
Lee, SR ;
AuBuchon, JP ;
Schreiber, GB ;
Williams, AE ;
Ownby, HE ;
Waxman, DA ;
Hutching, S ;
Murphy, EL ;
Gilcher, RO ;
Smith, JW ;
Thomson, RA ;
Nemo, GJ ;
Zuck, TF .
TRANSFUSION, 1995, 35 (11) :903-910
[8]   COST-EFFECTIVENESS OF ACCELERATED REHABILITATION AFTER PROXIMAL FEMORAL FRACTURE [J].
CAMERON, ID ;
LYLE, DM ;
QUINE, S .
JOURNAL OF CLINICAL EPIDEMIOLOGY, 1994, 47 (11) :1307-1313
[9]  
*CDCP, 1997, MMWR-MORBID MORTAL W, V46, P165
[10]  
CHAVEY WE, 1994, J FAM PRACTICE, V38, P249